Evidence map›Paper›PMID 36143085›Full record

ArticleJournal of clinical medicine2022

Extreme Hyperferritinemia: Causes and Prognosis.

Maxime Fauter, Sabine Mainbourg, Thomas El Jammal, Arthur Guerber, Sabine Zaepfel, Thomas Henry, Mathieu Gerfaud-Valentin, Pascal Sève, Yvan Jamilloux

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Making every test count: Insights from a test kit efficiency audit.African journal of laboratory medicine · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Toxicities Associated with CAR-T Cell Therapies.Mediterranean journal of hematology and infectious diseases · 2025
    Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Maxime FauterDepartment of Internal Medicine, University Hospital Croix-Rousse, Lyon 1 University, 69004 Lyon, France.ORCID 0000-0001-6761-8970
Sabine MainbourgDepartment of Internal Medicine and Vascular Pathology, University Hospital Lyon Sud, Lyon 1 University, 69000 Lyon, France.ORCID 0000-0003-4564-2931
Thomas El JammalDepartment of Internal Medicine, University Hospital Croix-Rousse, Lyon 1 University, 69004 Lyon, France.
Arthur GuerberDepartment of Internal Medicine, University Hospital Croix-Rousse, Lyon 1 University, 69004 Lyon, France.
Sabine ZaepfelDepartment of Biochemistry and Molecular Biology, University Hospital Croix-Rousse, Hospices Civils de Lyon, 69004 Lyon, France.
Thomas HenryCIRI, Centre International de Recherche en Infectiologie, Inserm U1111, Lyon 1 University, CNRS, UMR5308, ENS de Lyon, 69007 Lyon, France.ORCID 0000-0002-0687-8565
Mathieu Gerfaud-ValentinDepartment of Internal Medicine, University Hospital Croix-Rousse, Lyon 1 University, 69004 Lyon, France.ORCID 0000-0003-4245-8039
Pascal SèveDepartment of Internal Medicine, University Hospital Croix-Rousse, Lyon 1 University, 69004 Lyon, France.ORCID 0000-0003-3070-3842
Yvan JamillouxDepartment of Internal Medicine, University Hospital Croix-Rousse, Lyon 1 University, 69004 Lyon, France.ORCID 0000-0001-5249-3650
Université Claude Bernard Lyon 1 · FRHospices Civils de Lyon · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The significance of extreme hyperferritinemia and its association with certain diagnoses and prognoses are not well characterized. We performed a retrospective analysis of adult patients with at least one total serum ferritin (TSF) measurement ≥ 5000 µg/L over 2 years, in three university hospitals. Conditions associated with hyperferritinemia were collected, and patients were classified into 10 etiological groups. Intensive care unit (ICU) transfer and mortality rates were recorded. A total of 495 patients were identified, of which 56% had a TSF level between 5000 and 10,000 µg/L. There were multiple underlying causes in 81% of the patients. The most common causes were infections (38%), hemophagocytic lymphohistiocytosis (HLH, 18%), and acute hepatitis (14%). For TSF levels > 10,000 µg/L, there were no solid cancer or hematological malignancy without another cause of hyperferritinemia. Isolated iron-overload syndromes never exceeded TSF levels > 15,000 µg/L. Extreme hyperferritinemia (TSF levels > 25,000 µg/L) was associated with only four causes: HLH, infections, acute hepatitis and cytokine release syndromes. A total of 32% of patients were transferred to an ICU, and 28% died. Both ICU transfer rate and mortality were statistically associated with ferritin levels. An optimized threshold of 13,405 μg/L was the best predictor for the diagnosis of HLH, with a sensitivity of 76.4% and a specificity of 79.3%. Hyperferritinemia reflects a variety of conditions, but only four causes are associated with extreme hyperferritinemia, in which HLH and acute hepatitis are the most common. Extreme hyperferritinemia has a poor prognosis with increased mortality.

Indexed as

ferritinhemophagocytic lymphohistiocytosishyperferritinemiahyperferritinemic syndromeseptic shock

Identifiers

PMID36143085
PMCPMC9505036
OpenAlexW4296353935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.